Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20009422HPVENSG00000132965.10protein_codingALOX5APNoNo241A0A087WW23
P20292
TVIS20051418HPVENSG00000132965.10protein_codingALOX5APNoNo241A0A087WW23
P20292
TVIS20044890HPVENSG00000132965.10protein_codingALOX5APNoNo241A0A087WW23
P20292
TCGA Plot Options
Drug Information
GeneALOX5AP
DrugBank IDDB16346
Drug NameVeliflapon
Target IDBE0002382
UniProt IDP20292
Regulation Typeinhibitor
PubMed IDs19876784; 7741044; 11908571
CitationsSampson AP: FLAP inhibitors for the treatment of inflammatory diseases. Curr Opin Investig Drugs. 2009 Nov;10(11):1163-72.@@Hatzelmann A, Fruchtmann R, Mohrs KH, Raddatz S, Matzke M, Pleiss U, Keldenich J, Muller-Peddinghaus R: Mode of action of the leukotriene synthesis (FLAP) inhibitor BAY X 1005: implications for biological regulation of 5-lipoxygenase. Agents Actions. 1994 Nov;43(1-2):64-8. doi: 10.1007/BF02005767.@@He W, Pelletier JP, Martel-Pelletier J, Laufer S, Di Battista JA: Synthesis of interleukin 1beta, tumor necrosis factor-alpha, and interstitial collagenase (MMP-1) is eicosanoid dependent in human osteoarthritis synovial membrane explants: interactions with antiinflammatory cytokines. J Rheumatol. 2002 Mar;29(3):546-53.
GroupsInvestigational
Direct Classification
SMILESOC(=O)[C@H](C1CCCC1)C1=CC=C(OCC2=NC3=C(C=CC=C3)C=C2)C=C1
Pathways
PharmGKB
ChEMBLCHEMBL88712